InsidersTradesSigma
Track the Sunshine Biopharma, Inc share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Sunshine Biopharma, Inc has published 5 reports. Market capitalisation: €2.8m. The latest transaction was filed on 5 March 2024 (Acquisition). Among the most active insiders: Slilaty Steve N.. The full history is free.
5
Insider Decl.
n/a
Thresholds
€61,633
4 ops.
Buy Volume
€87,098
1 ops.
Sell Volume
45Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 5 March 2024
Declarations5 total
100,000 shares@ US$0.109.4% of flowSeries B Preferred StockSEC:0001683168-24-001322:0
Canonical exit: 2 Jun 2024 (T+90)
20,000 shares@ US$0.101.9% of flowSeries B Preferred StockSEC:0001683168-24-000879:0
Canonical exit: 8 May 2024 (T+90)
30,000 shares@ US$0.763543.9% of flowCommon StockSEC:0001683168-22-008144:0
Canonical exit: 28 Feb 2023 (T+90)
25,000 shares@ US$1.220.65% mcap100.0% of flowCommon StockSEC:0001683168-22-004178:0
Canonical exit: 1 Sept 2022 (T+90)
990,000 shares@ US$0.102.00% mcap100.0% of flowSeries B Preferred StockSEC:0001683168-22-001185:0
5 of 5 declarations
关于 Sunshine Biopharma, Inc
Sunshine Biopharma, Inc 是一家专注于开发治疗癌症和其他疾病药物的公司。它在纳斯达克上市，股票代码为 SBFM。